|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/14 | |
| C07D 413/14 | |||
| C07D 403/04 | |||
| C07D 403/14 | |||
| C07D 413/04 | |||
| C07D 417/04 | |||
| C07D 417/14 | |||
| C07D 419/04 | |||
| C07D 419/14 | |||
| A61K 31/41 | |||
| A61P 25/00 |
| (11) | Patento numeris | 2906553 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13805561.1 |
| Europos patento paraiškos padavimo data | 2013-10-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-08-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-06-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2013/059233 |
| Data | 2013-10-09 |
| (87) | Numeris | WO 2014/057435 |
| Data | 2014-04-17 |
| (30) | Numeris | Data | Šalis |
| 12188019 | 2012-10-10 | EP | |
| 13157809 | 2013-03-05 | EP |
| (72) |
BOLLI, Martin, CH
BOSS, Christoph, CH
BROTSCHI, Christine, CH
GUDE, Markus, CH
HEIDMANN, Bibia, CH
SIFFERLEN, Thierry, CH
WILLIAMS, Jodi T., CH
|
| (73) |
Idorsia Pharmaceuticals Ltd,
Hegenheimermattweg 91, 4123 Allschwil,
CH
|
| (54) | OREXIN RECEPTOR ANTAGONISTS WHICH ARE [ORTHO BI (HETERO )ARYL]-[2-(META BI (HETERO)ARYL)-PYRROLIDIN-1-YL]-METHANONE DERIVATIVES |
| OREXIN RECEPTOR ANTAGONISTS WHICH ARE [ORTHO BI (HETERO )ARYL]-[2-(META BI (HETERO)ARYL)-PYRROLIDIN-1-YL]-METHANONE DERIVATIVES |